Cardiovascular Therapeutics
Journal Title
- Cardiovascular Therapeutics
ISSN
- E 1755-5922 | P 1755-5914
Publisher
- Wiley-Blackwell
Listed on(Coverage)
| JCR | 2008-2019 |
|---|---|
| SJR | 2009-2019 |
| CiteScore | 2011-2019 |
| SCI | 2010-2019 |
| SCIE | 2010-2021 |
| CC | 2016-2021 |
| SCOPUS | 2017-2020 |
| MEDLINE | 2016-2021 |
| DOAJ | 2019-2021 |
| EMBASE | 2016-2020 |
OA Info.
| OA |
based on the information
|
|---|---|
| Keywords | cardiovascular pharmacology, cardiovascular drugs, cardiovascular diseases |
| Review Process | Blind peer review |
| Journal info. pages | |
| Licences | CC BY |
| Copyrights | Yes |
| DOAJ Coverage |
|
| Subject(s) | Medicine: Therapeutics. Pharmacology | Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- ENGLAND
Aime & Scopes
- Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged. Subject areas include (but are by no means limited to): /// Acute coronary syndrome /// Arrhythmias /// Atherosclerosis /// Basic cardiac electrophysiology /// Cardiac catheterization /// Cardiac remodeling /// Coagulation and thrombosis /// Diabetic cardiovascular disease /// Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF) /// Hyperlipidemia /// HypertensionIschemic heart diseaseVascular biology /// Ventricular assist devices /// Molecular cardio-biology /// Myocardial regeneration /// Lipoprotein metabolismRadial artery access /// Percutaneous coronary intervention /// Transcatheter aortic and mitral valve replacement